Most days, pharmaceutical distributors fulfill their vital role largely unnoticed. Patients take for granted their medications will reach them safely and quickly. They don’t think about the systems, protocols, professionalism and technology required to make delivery seamless from manufacturer to pharmacy and, ultimately, to them.
Step into a pharmaceutical distribution center, and you will find a modern facility bustling with activity. In today’s state-of-the-art facilities, passionate employees, supported by sophisticated new technology, work around the clock to fulfill shipments to hundreds of thousands of pharmacies, hospitals and other healthcare facilities across the country.
Patients often have many questions when they are prescribed a medication by their healthcare provider for the first time. What they typically do not need to worry about, however, is how their prescription medicine got to the pharmacy, whether anything happened to it along its journey, if it was handled with care or if it was potentially compromised by illegitimate products that may have entered the pharmaceutical supply chain.
Most Americans take for granted the complex pharmaceutical supply chain that ensures their medication arrives safely, reliably and efficiently at the pharmacy, doctor’s office or hospital. Have you ever wondered how pharmacies and healthcare providers keep these vital medicines in stock so that patients have access to medicines when they need them, even during weather emergencies?
As the logistics experts of healthcare, distributors deliver millions of prescription medicines and healthcare products to hundreds of thousands of providers, including pharmacies, hospitals and healthcare facilities, across the country. But their relationships with these customers is about more than just delivery — distributors offer additional services that allow their customers to focus on patients and remain competitive in the marketplace.
The opioid abuse epidemic is a complex and multifaceted issue that progressed over decades of federal policy and clinical practice that encouraged prescription opioids as the primary option for pain management. But recent media coverage does not provide the full picture and leaves out important details about the epidemic and its origins.
A comprehensive understanding of the multiple drivers of the opioid abuse epidemic is key to moving forward with solutions to address this public health crisis.
Last week, Allied Against Opioid Abuse (AAOA) partners, the National Community Pharmacists Association (NCPA) and the PA Foundation, joined HDA at the Distribution Management Conference and Expo (DMC) for a discussion about how we are working together to educate and raise awareness about the rights, risks and responsibilities associated with prescription opioids.
The HDA Research Foundation recently announced the selection of four inaugural recipients for its graduate-level scholarship. Established in conjunction with HDA’s Convene, the scholarship, sponsored by Teva Pharmaceuticals, is available annually to individuals with at least two years of service working within HDA-member distributor and manufacturer companies.
Pharmaceutical distributors deliver millions of medicines and healthcare products to providers nationwide — rain, snow or shine. Every day, hundreds of thousands of patients across the country depend on the uninterrupted delivery of prescription medicines, and pharmaceutical distributors work around the clock to ensure these products get to where they need to be, safely and efficiently. As winter marches on, with snowstorms and sub-zero temperatures in parts of the country, HDA member companies rise to the challenge of making sure vital medicines reach the people who need them, no matter what it takes.